Doc dr Ebrahimi Keramatollah
Doc dr Ebrahimi Keramatollah
Specific professional orientation:
Doctor Ebrahimi Keramatollah, better known as Dr. Keri, is an Iraqi physician who came to Belgrade in 1987 and enrolled in the Faculty of Medicine, continuing his studies until specialization in general surgery. He is employed at the First Surgical Clinic of the Clinical Center of Serbia. His primary focus is on gastrointestinal surgery.
Doctor Keramatollah specializes in surgical treatment of gastrointestinal diseases, as well as benign and malignant tumors of the esophagus, stomach, and duodenum. He is involved in scientific research in the field of esophageal and gastric cancer. Doctor
Keramatollah holds a doctoral degree in medical sciences and is highly respected among colleagues, being dedicated to working with students.
He has participated as a speaker and lecturer at numerous professional congresses and symposiums. Doctor Keramatollah Ebrahimi is the author and co-author of 34 professional papers published in reputable international and domestic journals.
Education:
- 1987 – 1997 University of Belgrade, Medical Faculty – Bachelor’s studies.
- 1999 – 2004 University of Belgrade, Medical Faculty – Specialization in General Surgery.
- 2010 – University of Belgrade, Medical Faculty- Master’s thesis titled: The significance of resective surgical procedures in the treatment of primary non-metastatic gastrointestinal stromal tumors (GIST) of the stomach.
- 2018 – University of Belgrade, Medical Faculty – Doctoral dissertation on the topic: The significance of mutations in the KIT and PDGFRA genes in evaluating the treatment of patients undergoing surgery for gastrointestinal stromal tumor of the stomach.
Working experience:
- 2003 – Clinic for Digestive Surgery, First Surgical Clinic of the Clinical Center of Serbia – Surgeon
- 2013 – Faculty of Medicine, University of Belgrade – Assistant at the Department of Surgery with Anaesthesiology
- 2018 – Works as a surgeon in multiple private institutions and hospitals.
Publications:
- The significance of mutations in the KIT and PDGFRA genes in evaluating the treatment of patients undergoing surgery for gastrointestinal stromal tumor of the stomach – Autor.
- Randomized double-blind study comparing TR-701 FA and Linezolid in Ventilator-Associated Gram-positive Nosocomial Pneumonia – Co-investigator.
Memberships:
Member of the Serbian Medical Society – SLD